Literature DB >> 2436055

AIDS vaccine predictions.

A R Coates, J Cookson, G J Barton, M J Zvelebil, M J Sternberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2436055     DOI： 10.1038/326549c0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Preparation and crystallization of a human immunodeficiency virus p24-Fab complex.

Authors:  A J Prongay; T J Smith; M G Rossmann; L S Ehrlich; C A Carter; J McClure
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus.

Authors:  Y H Chong; S L Payne; C J Issel; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.

Authors:  M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals.

Authors:  A Achour; O Picard; D Zagury; P S Sarin; R C Gallo; P H Naylor; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain.

Authors:  J C Lewthwaite; A R Coates; P Tormay; M Singh; P Mascagni; S Poole; M Roberts; L Sharp; B Henderson
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus.

Authors:  A A Minassian; V S Kalyanaraman; R C Gallo; M Popovic
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.

Authors:  R A Koup; C A Pikora; K Luzuriaga; D B Brettler; E S Day; G P Mazzara; J L Sullivan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: prediction of HIV p24 antigenic sites.

Authors:  P Argos
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.